Fresenius Medical Care operates a vertically integrated business model divided into two main segments: Care Delivery and Care Enablement. The Care Delivery segment provides patient treatments, operating more than 3,500 outpatient dialysis clinics worldwide with a particularly strong market presence in the United States. The Care Enablement segment focuses on the research, development, and manufacturing of essential medical products, including hemodialysis machines, dialyzers, and related consumables. These products are supplied both to the company's proprietary clinics and to third-party healthcare providers. In addition to traditional dialysis, the company is increasingly expanding into value-based care initiatives and home dialysis solutions to manage chronic kidney disease more holistically. This dual-faceted structure of clinical services and product manufacturing solidifies its dominant competitive position in the global renal care market.
